Viking Therapeutics, Inc. Recorded Big Gain
Tue, Sep 22, 2026 at 07:56 PM
Viking Therapeutics, Inc. (VKTX:NASDAQ) jumped higher at $40.85, a gain of 35.7%. On Tue, Sep 22, 2026, VKTX:NASDAQ touched a New 2-Week High of $40.85. The stock got featured on our News Catalysts scanner on Tue, Sep 22, 2026 at 06:45 PM in the 'MISCELLANEOUS' category. From Tue, Sep 08, 2026, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Jul 07, 2026 at $42.79 with a volume of 4M+.
About Viking Therapeutics, Inc. (VKTX:NASDAQ)
Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.
Top 10 Gainers:
- Jaguar Health, Inc. (JAGX:NASDAQ), 1190.64%
- Lianhe Sowell International Group Ltd (LHSW:NASDAQ), 105.33%
- Movella Holdings Inc. (MVLA:NASDAQ), 100%
- Zeo Energy Corp. (ZEO:NASDAQ), 57.04%
- Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ), 54.31%
- Greenland Mines Ltd (GRML:NASDAQ), 50.21%
- CaliberCos Inc. (CWD:NASDAQ), 40.33%
- Filana Therapeutics Inc. (FLNA:NASDAQ), 39.28%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 35.67%
- ZK International Group Co., Ltd. (ZKIN:NASDAQ), 35.51%